You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca has announced that it has entered into an agreement with Pfizer to sell the commercialisation and development rights to its late-stage small molecule antibiotics business in most markets globally outside the US. Under the terms of the agreement, Pfizer will make an upfront payment to Already a subscriber Login…
Klaria Pharma Holding has acquired Uppsalagruppen Medical AB and the patent that protects Klaria’s drug delivery technology, it has also merged with Karessa Pharma Holding to create a focused drug development company. Klaria Pharma Holding and Karessa Pharma Holding have jointly announced that Already a subscriber Login You have read…
NeuroVive Pharmaceutical announces two new research agreements and the appointment of Professor Philippe Gallay, PhD, and Professor Massimo Pinzani, MD, PhD, FRCP, as scientific advisors. The aim of the agreements is to further explore NeuroVive's new drug compounds in development for the treatmeAlready a subscriber Login You have read all…
AstraZeneca will collaborate with Accent Therapeutics to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins (RMPs) for the treatment of cancer. This collaboration focuses on targeting RMPs, proteins that control many aspects of RNA biology and represeAlready a subscriber Login You have read all your free articles, to continue…
